Malignant mesothelioma: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
| (2 intermediate revisions by the same user not shown) | |||
| Line 30: | Line 30: | ||
'''Malignant mesothelioma''', also '''mesothelioma''', is a form of [[cancer]]. It arises from the mesothelium. | '''Malignant mesothelioma''', also '''mesothelioma''', is a form of [[cancer]]. It arises from the mesothelium. | ||
It should '''not''' be confused with ''[[benign multicystic mesothelioma]]'' and ''[[benign papillary mesothelioma | It should '''not''' be confused with ''[[benign multicystic mesothelioma]]'' and ''[[well-differentiated papillary mesothelial tumour]]'' (previously ''benign papillary mesothelioma''). | ||
==General== | ==General== | ||
| Line 128: | Line 128: | ||
Note: | Note: | ||
*A simple pankeratin is useful for seeing where epithelial cells are. | |||
*A simple pankeratin is useful for | |||
Others: | Others: | ||
| Line 145: | Line 144: | ||
**D2-40. | **D2-40. | ||
**[[CK5/6]]. | **[[CK5/6]]. | ||
**[[CA-125]].<ref name=pmid9023557>{{cite journal |authors=Bateman AC, al-Talib RK, Newman T, Williams JH, Herbert A |title=Immunohistochemical phenotype of malignant mesothelioma: predictive value of CA125 and HBME-1 expression |journal=Histopathology |volume=30 |issue=1 |pages=49–56 |date=January 1997 |pmid=9023557 |doi=10.1046/j.1365-2559.1996.d01-562.x |url=}}</ref> | |||
*Carcinoma markers: | *Carcinoma markers: | ||
**CEA (monoclonal and polyclonal). | **CEA (monoclonal and polyclonal). | ||